RNase Inhibitor, Human Placenta

#M0307

recombinant
Catalog # Size Concentration Price (£)
M0307L 10000 UNITS 40,000 units/ml £288.00
M0307S 2000 UNITS 40,000 units/ml £73.00

RNase Inhibitor, Human Placenta, specifically inhibits RNases A, B and C.

  • Isolated from a recombinant source

  • Inhibits common eukaryotic RNases

  • Compatible with Taq DNA Polymerase, AMV or M-MuLV Reverse Transcriptases

  • Active over a broad pH range (pH 5-8)

  • Tested for the absence of DNases and RNases

RNase Inhibitor, Human Placenta is a recombinant human placental protein which specifically inhibits ribonucleases (RNases) A, B and C (1). It is not effective against RNase 1, RNase T1, S1 Nuclease, RNase H or RNase from Aspergillus. In addition, no inhibition of polymerase activity is observed when RNase Inhibitor, Human Placenta is used with Taq DNA Polymerase, AMV or M-MuLV Reverse Transcriptases, or Phage RNA Polymerases (SP6, T7, or T3).

The 50 kDa protein inhibits RNases by binding noncovalently in a 1:1 ratio with an association constant greater than 1014 (2).

Product Source

An E. coli strain that carries the Ribonuclease Inhibitor gene from human placenta.

Reagents Supplied

The following reagents are supplied with this product:

NEB #

Component Name

Component #

Stored at (°C)

Amount

Concentration

  • M0307S

     

     

    -20

     

     

  • M0307L

     

     

    -20

     

     

Properties & Usage

Product Notes

References

Protocols

Datacards

Quality Control Assays

Certificate of Analysis

Specifications & Change Notifications

The Specification sheet is a document that includes the storage temperature, shelf life and the specifications designated for the product. The following file naming structure is used to name these document files: [Product Number]_[Size]_[Version]

The following link is to a PDF Safety Data Sheet (SDS) that applies to this product to help you use it safely.



Datacards

Legal and Disclaimers



ADDED